A Case of Tuberculous Liver Abscess Developed during Chemotherapy for Tuberculous Peritonitis as Paradoxical Response.
- Author:
Tae Kyung KIM
1
;
Cheol Woong CHOI
;
Jong Kun HA
;
Hyung Ha JANG
;
Su Bum PARK
;
Hyung Wook KIM
;
Dae Hwan KANG
Author Information
- Publication Type:Case Reports ; English Abstract
- Keywords: Paradoxical response; Tuberculous liver abscess; Tuberculous peritonitis
- MeSH: Antitubercular Agents/*adverse effects/*therapeutic use; DNA, Bacterial/analysis; Humans; Laparoscopy; Liver/pathology/ultrasonography; Liver Abscess/*chemically induced/*diagnosis/microbiology; Male; Mycobacterium tuberculosis/genetics/isolation & purification; Necrosis/pathology; Peritoneum/pathology; Peritonitis, Tuberculous/*drug therapy; Tomography, X-Ray Computed; Tuberculosis/*diagnosis/microbiology; Young Adult
- From:The Korean Journal of Gastroenterology 2013;62(1):64-68
- CountryRepublic of Korea
- Language:Korean
- Abstract: Tuberculous liver abscesses are rare. Paradoxical response in tuberculosis is common and occurred between 2 weeks and 12 weeks after anti-tuberculous medication. We report here a case of tuberculous liver abscess that developed in a paradoxical response during chemotherapy for tuberculous peritonitis in a 23-year-old male. He was hospitalized, complaining of ascites, epigastric pain. He was diagnosed tuberculous peritonitis by expiratory laparoscopic biopsy and took medication for tuberculosis. After 2 months, a hepatic lesion was detected with CT scan incidentally. Chronic granulomatous inflammation was seen in ultrasound-guided liver biopsy, and tuberculous liver abscess was diasnosed. It was considered as paradoxical response, rather than treatment failure or other else because clinical symptoms of peritoneal tuberculosis and CT scan improved. After continuing initial anti-tuberculous medication, he was successfully treated. Herein, we report a case of tuberculous liver abscess as paradoxical response while treating peritoneal tuberculosis without changing anti-tuberculous treatment regimen.